Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK OFF JSpA)

Primary Objective

Aim 1. To compare the likelihood of disease flare associated with fixed standard dosing, fixed longer dosing intervals, or stopping TNFi in children with spondyloarthritis who have inactive disease. Aim 2. To compare patients lived experiences in the three treatment arms (Standard dosing TNFi, Tapered dosing TNFi, and TNFi withdrawal).

Study category: Bones, Muscles, and Joints

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Type of Study

Treatment

Scope

National

Locations

Childrens Hospital Colorado

Principal Investigator
Jennifer Cooper,  MD

Jennifer Cooper, MD

Study ID

Protocol Number: 21-4033

More information available at ClinicalTrials.gov: NCT04891640

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers